FHIR © HL7.org  |  Server Home  |  XIG Home  |  Server Source  |  FHIR  

FHIR IG Statistics: FHIR Resources

Resources - All Kinds, Realm US, Authority Hl7

16,284 resources

Type: Text:

By Version

 

Start Prev Rows 8400 - 8600 Next

PackageVersionIdentityName/TitleStatusFMMWGDate
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1178.35Aspirin or Clopidogrelactive2024-02
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1178.39Cardiac Rehabilitationactive2024-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1178.4Hypothyroidismactive2021-04
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1178.40Cardiac Rehabilitationactive2022-07
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1178.43SGLT2 Ingredientsactive2022-07
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1178.44MRA Ingredientsactive2022-07
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1178.49Minnesota Living with Heart Failure Questionnaireactive2022-07
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1178.5Hypothyroidismactive2024-02
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1178.50Kansas City Cardiomyopathy Questionnaireactive2022-07
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1178.51Cardiac Paceractive2021-11
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1178.52Cardiac Paceractive2025-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1178.53Cardiac Paceractive2022-02
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1178.54Heart Transplant Complicationsactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1178.55Heart Transplant Complicationsactive2025-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1178.56Heart Transplant Complicationsactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1178.57Left Ventricular Assist Device Complicationsactive2022-02
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1178.58Left Ventricular Assist Device Complicationsactive2022-02
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1178.59Left Ventricular Assist Device Placementactive2023-02
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1178.6Hypothyroidismactive2021-04
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1178.60Left Ventricular Assist Device Placementactive2023-02
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1178.61Left Ventricular Assist Device Placementactive2022-02
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1178.62Left Ventricular Assist Device Placementactive2022-02
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1178.63Heart Transplantactive2022-07
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1178.65Cardiac Paceractive2022-11
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1178.66Diastolic Heart Failureactive2023-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1178.67Diastolic Heart Failureactive2023-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1178.68Diastolic Heart Failureactive2022-02
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1178.69Allergy to SGLT2 Inhibitorsactive2023-02
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1178.7Anorexia Nervosaactive2023-02
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1178.70Intolerance to SGLT2 Inhibitorsactive2022-07
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1178.71Intolerance to MRA Therapyactive2022-07
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1178.72ARNI Ingredientactive2022-02
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1178.73Mitral Stenosisactive2022-02
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1178.74Mitral Stenosisactive2022-02
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1178.75Mitral Stenosisactive2022-02
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1178.76Mechanical Prosthetic Heart Valveactive2022-11
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1178.77Mechanical Prosthetic Heart Valveactive2025-04
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1178.78Mechanical Prosthetic Heart Valveactive2022-02
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1178.79Mechanical Prosthetic Heart Valve in Situactive2022-02
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1178.8Anorexia Nervosaactive2021-04
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1178.82Systolic Heart Failureactive2023-03
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1178.83Systolic Heart Failureactive2023-03
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1178.84Systolic Heart Failureactive2023-03
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1178.85Carotid Interventionactive2023-03
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1178.86Serum Creatinineactive2023-10
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1178.87Urine Creatinineactive2025-03
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1178.88Urine Albuminactive2023-10
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1178.9Anorexia Nervosaactive2021-04
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1178.90Non Steroidal Mineralcorticoid Receptor Antagonistactive2024-10
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1178.91Glucagon like peptide 1 medicationsactive2024-11
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1178.96AHA GWTG Long COVID19active2024-10
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1181.1Wound internal item and/or body structure visible value set (foundation metadata concept)active2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1181.11Wound exudate appearance value set (foundation metadata concept)active2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1181.12Wound exudate color value set (foundation metadata concept)active2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1181.13Exudate odor value set (foundation metadata concept)active2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1181.16Skin temperature value set (foundation metadata concept)active2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1181.17Skin color enumerated value set (foundation metadata concept)active2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1181.18Skin turgor value set (foundation metadata concept)active2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1181.19Skin and mucous membrane integrity value set (foundation metadata concept)active2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1181.2Periwound condition value set (foundation metadata concept)active2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1181.20Skin moisture value set (foundation metadata concept)active2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1181.3Wound Type Etiology value setactive2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1181.4Wound episode value set (foundation metadata concept)active2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1181.6Wound bed appearance value set (foundation metadata concept)active2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1181.60Wound type reference setactive2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1181.7Wound bed color value set (foundation metadata concept)active2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1181.74Nonverbal pain indicators reference setactive2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1181.76Pain associated signs and symptoms reference setactive2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1181.77Pain body location reference setactive2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1181.8Wound edge description value set (foundation metadata concept)active2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1181.80Pain quality reference setactive2025-03
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1181.81Pain speed of onset reference setactive2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1181.9Presence absence value set (foundation metadata concept)active2018-07
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1186.1Common drug substances for allergy and intolerance documentationactive2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1186.2Common drug classes for allergy and intolerance documentationactive2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1186.3Common dietary substances for allergy and intolerance documentationactive2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1186.4Common environmental substances for allergy and intolerance documentationactive2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1190.10NHSNCriterionOfDiagnosisCode(CDCNHSN)active2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1190.11NHSNCriterionOfDiagnosisCode(SNOMEDCT)active2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1190.12NHSNInfectionConditionCode(CDCNHSN)active2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1190.13NHSNInfectionConditionCode(SNOMEDCT)active2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1190.14NHSNInfectionTypeCode(CDCNHSN)active2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1190.15NHSNInfectionTypeCode(SNOMEDCT)active2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1190.16NHSNInfectionFirstReportedSource(CDCNHSN)active2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1190.17NHSNInfectionFirstReportedSource(SNOMEDCT)active2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1190.18NHSNLOS/MENDischargeDisposition(CDCNHSN)active2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1190.19NHSNLOS/MENDischargeDisposition(SNOMEDCT)active2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1190.20NHSNPopulationSummaryReportTypeCode(CDCNHSN)active2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1190.21NHSNPopulationSummaryReportTypeCode(LOINC)active2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1190.22NHSNSameDayOutcomeMeasure(CDCNHSN)active2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1190.23NHSNSameDayOutcomeMeasure(SNOMEDCT)active2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1190.24NHSNSignificantPathogenCode(CDCNHSN)active2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1190.25NHSNSignificantPathogenCode(SNOMEDCT)active2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1190.26NHSNSpinalFusionApproachCode(CDCNHSN)active2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1190.27NHSNSpinalFusionApproachCode(SNOMEDCT)active2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1190.28NHSNVascularAccessTypeCode(CDCNHSN)active2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1190.29NHSNVascularAccessTypeCode(SNOMEDCT)active2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1190.30NHSNVascularSpecimenCollectionSite(CDCNHSN)active2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1190.31NHSNVascularSpecimenCollectionSite(SNOMEDCT)active2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1190.38Blood Glucose Laboratory and Point of Care Testsactive2023-09
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1190.6NHSNPathogenCodeAROactive2025-03
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1190.63Bacterial and Fungal Blood Culture Testsactive2022-07
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1190.7NHSNRoleOfPerformerCode(CDCNHSN)active2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1190.74Enteral Medication Routeactive2022-07
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1190.75Intravenous Medication Routeactive2022-07
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1190.79Fidaxomicin, Vancomycin, and Metronidazoleactive2022-07
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1190.8NHSNRoleOfPerformerCode(SNOMEDCT)active2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1190.85Baloxaviractive2023-05
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1190.86Peramiviractive2023-05
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1190.87Zanamiviractive2023-05
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1190.88Digestive, Intramuscular, Intravenous Route of Administrationactive2023-10
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1190.9NHSNRoleOfPerformerCode(HealthCareProviderTaxonomy)active2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1190.90NHSN LTC AU Antimicrobial Agentsactive2024-05
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1190.91Long Term Care Discharge Dispositionactive2024-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1190.94NHSNNeurogenicBladderactive2025-03
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1190.95NHSNSpinalCordInjuryactive2025-03
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1196.147SCIP Major Surgical Procedureactive2019-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1196.3483Financial Insecurity Screening Assessments Questionsactive2023-07
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1196.3484Food Insecurity Screening Assessments Questionsactive2023-07
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1196.3485Health Literacy Screening Assessments Questionsactive2024-12
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1196.3486Homelessness Screening Assessments Questionsactive2023-08
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1196.3487Housing Instability Screening Assessments Questionsactive2023-08
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1196.3488Less Than High School Education Screening Assessments Questionsactive2023-07
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1196.3519Health Insurance Coverage Status Screening Assessments And Questionsactive2023-07
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1196.3520Inadequate Housing Screening Assessments And Questionsactive2023-07
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1196.393Hypoglycemics Severe Hypoglycemiaactive2024-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1196.394Hypoglycemics Treatment Medicationsactive2025-02
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1196.4448Lidocaineactive2024-05
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1196.491Medium Dose ICS Formoterol Preparationsactive2021-09
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1196.495ICS LABA LAMA Preparationsactive2021-09
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1196.788Social Determinants of Health Conditionsactive2024-12
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1206.15General Surgeryactive2020-04
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1206.17Coagulation Disorder Conditionsactive2020-04
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1206.19Anticoagulant Medicationsactive2025-02
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1206.20Anticoagulant Medications, Oralactive2024-03
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1206.21Anticoagulant Medications, Injectionactive2024-03
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1206.28Active Bleedingactive2020-11
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1206.29Fall Risk Increasing Drugs (FRIDs)active2021-07
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1206.30Fall Risk Factorsactive2021-02
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1206.32Total Hip Arthroplasty Surgeryactive2021-03
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1206.33Total Knee Arthroplasty Surgeryactive2021-03
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1206.46Opioid Medicationsactive2021-07
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1206.47Imaging Related to VTEactive2023-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1206.48Anticoagulant Medicationactive2024-03
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1206.49VTE Diagnosesactive2025-02
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1206.50Bisphosphonate Therapyactive2022-02
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1206.51VTE Symptomsactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1206.52Oncology Critical Care Unitsactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1206.53Provider Typesactive2022-05
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1206.56FOBT_Labactive2024-07
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1206.58Screening Mammogram (CPT)active2024-08
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1206.59Screening Mammogram (LOINC)active2024-09
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1206.60Screening Mammogram (SNOMEDCT)active2024-08
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1206.61Screening Mammogram (Grouping)active2024-08
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1206.62Diagnostic Mammography (CPT)active2024-08
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1206.63Diagnostic Mammography (LOINC)active2024-09
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1206.64Diagnostic Mammography (SNOMEDCT)active2024-08
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1206.65Diagnostic Mammographyactive2024-08
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1206.66Breast Cancer Biopsy and Surgical Excisionactive2024-10
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1206.67BI_RADS Categories 0, 4, and 5active2024-10
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1206.68BI_RADS Categories 1, 2, and 3active2024-10
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1213.101Local Anestheticsactive2023-07
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1213.102Ophthalmic Epinephrinesactive2023-07
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1213.103Inhaled Epinephrinesactive2023-07
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1213.104Clopidogrelsactive2023-10
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1213.105Cytochrome P450 2C19 inhibitorsactive2023-10
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1213.107Aspirin Ingredient and Risk of GI Bleedingactive2023-12
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1213.109Oral Anticoagulant Ingredients and Risk of GI Bleedingactive2023-12
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1213.112PPI and Risk of GI Bleedingactive2023-12
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1213.113Antiplatelet Ingredients and Risk of GI Bleedingactive2023-12
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1213.115Kratom containing compoundsactive2024-07
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1213.117Clopidogrel Ingredients and Risk of GI Bleedingactive2024-09
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1213.121Gastrointestinal bleeding episode and Risk of GI Bleeding 1active2024-10
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1213.122Gastrointestinal bleeding episode and Risk of GI Bleeding 2active2024-09
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1213.123Gastrointestinal bleeding episode and Risk of GI Bleedingactive2024-09
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1213.24Oxycodonesactive2024-07
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1219.1Bronchiectasis Disorder SNOMEDactive2020-04
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1219.10Interstitial Lung Disease ICD10CMactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1219.100Occupational Therapy Procedure HCPCSactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1219.101Occupational Therapy Procedureactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1219.102Speech Language Therapy Procedure HCPCSactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1219.103Speech Language Therapy Procedureactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1219.104Home Health Procedureactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1219.105Intermittent Skilled Nursing Home Health Procedureactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1219.106pH, Hematocrit, Partial Pressure Carbon Dioxide, Partial Pressure Oxygen or Bicarbonate Laboratory Test for Breathing Assistance Device Evaluation Excluding Oxygen Saturationactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1219.107Breathing Test Procedure During Sleepactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1219.108Ambulance Transport Procedureactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1219.109Prefabricated Spinal Orthotic Deviceactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1219.11Interstitial Lung Disease SNOMEDCTactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1219.110Custom Fitted Spinal Orthotic Deviceactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1219.111Custom Fabricated Spinal Orthotic Deviceactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1219.112Orthotic Device Supplyactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1219.113Spinal Orthotic Device or Supplyactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1219.115Spine or Neck Disorder SNOMED CTactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1219.116Spine or Neck Disorder ICD10CMactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1219.117Spine or Neck Disorderactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1219.118Total Electric Hospital Bed Supplyactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1219.119Hypoventilation Disorder SNOMEDCTactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1219.12Interstitial Lung Diseaseactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1219.120Hypoventilation Disorder ICD10CMactive2022-03